Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12237112rdf:typepubmed:Citationlld:pubmed
pubmed-article:12237112lifeskim:mentionsumls-concept:C0245726lld:lifeskim
pubmed-article:12237112lifeskim:mentionsumls-concept:C0425152lld:lifeskim
pubmed-article:12237112lifeskim:mentionsumls-concept:C1310696lld:lifeskim
pubmed-article:12237112lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:12237112lifeskim:mentionsumls-concept:C2265920lld:lifeskim
pubmed-article:12237112lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:12237112lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:12237112pubmed:issue2lld:pubmed
pubmed-article:12237112pubmed:dateCreated2002-9-18lld:pubmed
pubmed-article:12237112pubmed:abstractTextThe involvement of phosphoinositide 3-kinase C2alpha in vascular smooth muscle cell migration was investigated. Products of phosphoinositide 3-kinase, phosphatidylinositol-3-phosphate, and phosphatidylinositol-3,4-bis-phosphate were increased upon smooth muscle cell migration but their synthesis was affected only partially by phosphoinositide 3-kinase inhibitors, wortmannin and LY-294002. Using specific antibody, we showed that the wortmannin/LY-294002 poorly sensitive phosphoinositide 3-kinase C2alpha is expressed in smooth muscle cells. Measurement of phosphoinositide 3-kinase C2alpha activity in vitro, after immunoprecipitation, clearly demonstrated its activation upon smooth muscle cell migration. Moreover, for the first time, phosphoinositide 3-kinase C2alpha was found to be differentially regulated by alpha(v)beta(3) and alpha(v)beta(5) integrin engagement. Finally, we have identified two new potential phosphoinositide 3-kinase C2alpha-binding proteins, p70 and p110, which both may be tyrosine phosphorylated. Thus, phosphoinositide 3-kinase C2alpha might represent a new regulatory pathway of cell migration downstream of integrin engagement.lld:pubmed
pubmed-article:12237112pubmed:languageenglld:pubmed
pubmed-article:12237112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:citationSubsetIMlld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12237112pubmed:statusMEDLINElld:pubmed
pubmed-article:12237112pubmed:monthSeplld:pubmed
pubmed-article:12237112pubmed:issn0006-291Xlld:pubmed
pubmed-article:12237112pubmed:authorpubmed-author:ChapHuguesHlld:pubmed
pubmed-article:12237112pubmed:authorpubmed-author:PerretBertran...lld:pubmed
pubmed-article:12237112pubmed:authorpubmed-author:PaulheFrédéri...lld:pubmed
pubmed-article:12237112pubmed:authorpubmed-author:IbergNiggiNlld:pubmed
pubmed-article:12237112pubmed:authorpubmed-author:MorandOlivier...lld:pubmed
pubmed-article:12237112pubmed:authorpubmed-author:Racaud-Sultan...lld:pubmed
pubmed-article:12237112pubmed:issnTypePrintlld:pubmed
pubmed-article:12237112pubmed:day20lld:pubmed
pubmed-article:12237112pubmed:volume297lld:pubmed
pubmed-article:12237112pubmed:ownerNLMlld:pubmed
pubmed-article:12237112pubmed:authorsCompleteYlld:pubmed
pubmed-article:12237112pubmed:pagination261-6lld:pubmed
pubmed-article:12237112pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:meshHeadingpubmed-meshheading:12237112...lld:pubmed
pubmed-article:12237112pubmed:year2002lld:pubmed
pubmed-article:12237112pubmed:articleTitlePhosphoinositide 3-kinase C2alpha is activated upon smooth muscle cell migration and regulated by alpha(v)beta(3) integrin engagement.lld:pubmed
pubmed-article:12237112pubmed:affiliationInstitut Fédératif de Recherche Claude de Préval, INSERM, Unité 563, Hôpital Purpan, Toulouse Cedex F31059, France.lld:pubmed
pubmed-article:12237112pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12237112pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3685entrezgene:pubmedpubmed-article:12237112lld:entrezgene
entrez-gene:3690entrezgene:pubmedpubmed-article:12237112lld:entrezgene
entrez-gene:5286entrezgene:pubmedpubmed-article:12237112lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12237112lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12237112lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:12237112lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12237112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12237112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12237112lld:pubmed